Company Filing History:
2 out of 2 
2 out of 2 Years Active: 2016-2017
Title: Innovations in Medicine by Junhuai Li
Introduction
Junhuai Li is a prominent inventor based in Province, China. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of inflammatory bowel disease (IBD). With a total of 2 patents, his work has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Junhuai Li's latest patents focus on the application of derivatives of the CZLC31 protein for the preparation of medicines aimed at preventing and treating IBD. One of his inventions introduces the CZLC331 protein, which has demonstrated a good preventive and therapeutic effect for conditions such as ulcerative colitis (UC) and Crohn's disease (CD). This protein can be formulated into a drug that not only prevents and treats IBD but also significantly reduces the side effects associated with existing clinical IBD medications. The invention aims to alleviate patient pain during treatment and has shown promise in improving rehabilitation and overall quality of life for patients.
Another patent also highlights the application of a flagellin derivative CZLC31 in the same context. The findings suggest that this derivative can similarly enhance the efficacy of treatments for IBD, offering a new avenue for therapeutic intervention.
Career Highlights
Throughout his career, Junhuai Li has worked with notable organizations, including Suzhou Sciscape Biomedicine Science & Technology Co. Ltd. and the Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China. His experience in these institutions has contributed to his innovative research and development in the medical field.
Collaborations
Junhuai Li has collaborated with esteemed colleagues such as Chenggang Zhang and Yang Xu. Their combined expertise has further advanced the research and applications of his inventions.
Conclusion
Junhuai Li's contributions to the field of medicine, particularly in the treatment of inflammatory bowel disease, showcase his innovative spirit and dedication to improving patient outcomes. His patents represent a significant step forward in medical science, with the potential for broad application in clinical settings.